Peregrine Ventures
Peregrine Ventures
Global life science venture capital fund investing in medical innovation from seed to growth stages.
About
Peregrine Ventures is a leading global life science venture capital fund focused on advancing medical innovation. They invest across the entire corporate lifecycle, from pre-seed incubation through growth stages, with a particular emphasis on medical devices, pharmaceuticals, biotech, and digital health. Their strategy involves providing strategic investments and expert guidance to help companies bring groundbreaking medical technologies to market.
Key facts
- Website
- peregrinevc.com
- Type
- VC
- Headquarters
- Or Yehuda, Israel
- Funds raised
- $600M
- Portfolio companies
- 39
- Stages
- Pre-SeedSeedSeries ASeries BSeries C
- Cheque size
- $586K to $105M
- Sector focus
- SpeechHealthcareVoice AnalysisHeart FailureMonitoring
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 28 Jan 2025 | Lutris Pharma | Series A | $30M |
| 6 May 2024 | 178854 | Series C | $10M |
| 28 Feb 2024 | 178854 | Grant | $3M |
| 23 Jan 2024 | Bluewhite | Series C | $39M |
| 20 Nov 2023 | Kanso Diagnostics | Seed | Undisclosed |
| 18 Oct 2023 | Variantyx | Series D | Undisclosed |
| 9 Oct 2023 | Wanda Fish | Seed | $7M |
| 30 Jul 2023 | xFind.ai | Pre-Seed | $3M |
| 1 Jun 2023 | Mush Foods | Seed | $12M |
| 24 Jan 2023 | Forsea | Seed | $16M |
Add first review
Frequently asked
What companies has Peregrine Ventures invested in?
Peregrine Ventures has invested in Lutris Pharma, 178854, Bluewhite, Kanso Diagnostics, Variantyx and 34 more.
AUM
$600M
PORTFOLIO
39